title: Mycobacterium abscessus scleritis following intravitreous injection of bevacizumab.
authors.forename: Jeffery R
authors.initials: JR
authors.lastname: Golen
authors.forename: Edgar M
authors.initials: EM
authors.lastname: Espana
authors.forename: Curtis E
authors.initials: CE
authors.lastname: Margo
mesh_terms: D000369:Aged, 80 and over; D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D000068258:Bevacizumab; D004269:DNA, Bacterial / Q000235:genetics; D015818:Eye Infections, Bacterial / Q000175:diagnosis / Q000382:microbiology*; D005260:Female; D006801:Humans; D058449:Intravitreal Injections / Q000009:adverse effects*; D009165:Mycobacterium Infections, Nontuberculous / Q000175:diagnosis / Q000382:microbiology*; D009170:Nontuberculous Mycobacteria / Q000235:genetics / Q000302:isolation & purification*; D011677:Punctures; D012329:RNA, Bacterial / Q000235:genetics; D012336:RNA, Ribosomal, 16S / Q000235:genetics; D015423:Scleritis / Q000175:diagnosis / Q000382:microbiology*; D057135:Wet Macular Degeneration / Q000188:drug therapy
chemical_list: D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized; D004269:DNA, Bacterial; D012329:RNA, Bacterial; D012336:RNA, Ribosomal, 16S; D000068258:Bevacizumab